Cargando…
The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits red...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423013/ https://www.ncbi.nlm.nih.gov/pubmed/28482834 http://dx.doi.org/10.1186/s12913-017-2248-6 |
_version_ | 1783234883278077952 |
---|---|
author | Berta, Paolo Levaggi, Rosella Martini, Gianmaria Verzillo, Stefano |
author_facet | Berta, Paolo Levaggi, Rosella Martini, Gianmaria Verzillo, Stefano |
author_sort | Berta, Paolo |
collection | PubMed |
description | BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits redistribution. METHODS: We use a rich administrative dataset gathering information on patients demand (whose records have been matched to income declared for tax purposes) to study the effects of an additional copayment (the so called “superticket” introduced by the Italian government in 2012) in Lombardy, the biggest Italian Region whose socio-economic dimension is comparable to that of many European countries (e.g., the Netherlands, Switzerland, etc.). RESULTS: Our analysis shows that at the aggregate level the non-uniform superticket schedule adopted in Lombardy is slightly pro-poor, but this result coexists with evidences pointing towards possible cases of restriction to access caused by the additional copayment. CONCLUSIONS: The introduction of the superticket and the ensuing increase in the out-of pocket payment for health care raises questions about the distribution of the burden among patients, and the sustainability of the extra revenue through time. This issue needs to be further investigated by combining health status data with the information in this dataset. |
format | Online Article Text |
id | pubmed-5423013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54230132017-05-10 The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy Berta, Paolo Levaggi, Rosella Martini, Gianmaria Verzillo, Stefano BMC Health Serv Res Research Article BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits redistribution. METHODS: We use a rich administrative dataset gathering information on patients demand (whose records have been matched to income declared for tax purposes) to study the effects of an additional copayment (the so called “superticket” introduced by the Italian government in 2012) in Lombardy, the biggest Italian Region whose socio-economic dimension is comparable to that of many European countries (e.g., the Netherlands, Switzerland, etc.). RESULTS: Our analysis shows that at the aggregate level the non-uniform superticket schedule adopted in Lombardy is slightly pro-poor, but this result coexists with evidences pointing towards possible cases of restriction to access caused by the additional copayment. CONCLUSIONS: The introduction of the superticket and the ensuing increase in the out-of pocket payment for health care raises questions about the distribution of the burden among patients, and the sustainability of the extra revenue through time. This issue needs to be further investigated by combining health status data with the information in this dataset. BioMed Central 2017-05-08 /pmc/articles/PMC5423013/ /pubmed/28482834 http://dx.doi.org/10.1186/s12913-017-2248-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Berta, Paolo Levaggi, Rosella Martini, Gianmaria Verzillo, Stefano The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title | The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title_full | The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title_fullStr | The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title_full_unstemmed | The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title_short | The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy |
title_sort | redistributive effects of copayment in outpatient prescriptions: evidence from lombardy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423013/ https://www.ncbi.nlm.nih.gov/pubmed/28482834 http://dx.doi.org/10.1186/s12913-017-2248-6 |
work_keys_str_mv | AT bertapaolo theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT levaggirosella theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT martinigianmaria theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT verzillostefano theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT bertapaolo redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT levaggirosella redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT martinigianmaria redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy AT verzillostefano redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy |